Sorbitrate
Sorbitrate Price range: $ 18,00 through $ 38,00
Back to products
Super Tadarise
Super Tadarise Price range: $ 35,00 through $ 318,00

Sotret

Price range: $ 24,00 through $ 70,00

Sotret is a potent oral medication specifically designed to combat severe, persistent nodular acne that has not responded to other treatments. By targeting the root causes of breakouts, this retinoid works to significantly reduce the excessive production of natural skin oils. It effectively shrinks sebaceous glands and prevents the formation of clogged pores, leading to a clearer and smoother complexion over time. Many individuals experience long-lasting results and a substantial improvement in their overall skin texture and appearance. This high-quality treatment is a reliable solution for those seeking a powerful approach to managing difficult skin conditions.

Active substance: Isotretinoin
SKU: Sotret Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Sotret should only be used under strict medical supervision due to significant clinical risks and boxed safety warnings. It is prescribed primarily for severe recalcitrant nodular acne that has failed to respond to conventional therapies, including systemic antibiotics. Because isotretinoin carries extreme risks of severe birth defects, patients in the United States must strictly adhere to the mandatory FDA-approved iPLEDGE REMS program.

This systemic oral retinoid requires rigorous clinical monitoring before, during, and after treatment to protect patient health. Understanding the medication’s mechanisms, contraindications, and potential adverse reactions is essential for minimizing severe health risks throughout the therapeutic course.

Basic Product Information
Parameter Details
Active Ingredient (INN) Isotretinoin
Therapeutic Class Systemic Retinoid / Acne Therapy
Dosage Form Oral capsule
Prescription Status Prescription (Rx only; subject to FDA iPLEDGE program)
Primary Purpose Severe recalcitrant nodular acne resistant to prior therapy
Food Administration Take with food (preferably high-fat meals) to maximize absorption

Key Safety Overview and Medical Information

What it’s used for

Sotret is indicated specifically for the medical management of severe, recalcitrant nodular acne in non-pregnant patients. Nodular acne involves hard, painful, inflammatory lesions measuring 5 mm or greater in diameter that deeply affect skin tissues. Because of its potential for serious adverse reactions, Sotret is reserved exclusively for patients who have demonstrated resistance to standard systemic acne therapies, including oral antibacterial agents. Off-label use for mild or moderate acne is not recommended due to an unfavorable risk-benefit ratio. Healthcare providers evaluate each patient carefully to confirm eligibility before prescribing this agent.

How the drug works

Sotret contains isotretinoin, a synthetic retinoid chemically related to vitamin A. The exact clinical mechanism of action is complex, but isotretinoin significantly decreases sebaceous gland size and suppresses sebaceous gland activity. By markedly reducing cutaneous sebum production, the drug alters the microenvironment of the skin follicle, thereby decreasing colonization by Cutibacterium acnes (formerly Propionibacterium acnes). In addition, isotretinoin exhibits potent anti-inflammatory effects within the dermis and normalizes keratinization within the follicular epithelium, which prevents the formation of microcomedones and inflammatory acne lesions.

How to take it

Sotret capsules must be taken orally exactly as directed by a licensed healthcare provider. The daily dosage is individualized and calculated strictly based on patient body weight, typically administered in two divided doses per day. To ensure optimal systemic absorption, capsules should be swallowed whole with food, ideally during meals containing dietary fat, as gastrointestinal absorption drops significantly when taken on an empty stomach. Patients must never chew, crush, or break open the capsules. A standard course of therapy usually spans 15 to 20 weeks. If severe nodular acne recurs after therapy, a second treatment course may be considered only after a mandatory rest period determined by the physician.

How it’s absorbed and eliminated

Following oral administration, isotretinoin bioavailability is variable and enhanced substantially when ingested alongside fat-containing foods. Peak plasma concentrations are typically reached within a few hours post-dose. Isotretinoin is bound extensively to human plasma proteins, predominantly albumin, at rates exceeding 99%. Hepatic metabolism occurs via cytochrome P450 enzymes into major active metabolites, including 4-oxo-isotretinoin. Excretion occurs via both renal and biliary pathways. The terminal elimination half-life of isotretinoin averages approximately 10 to 20 hours, whereas active metabolite half-lives can extend significantly longer.

What not to combine

Warning: Concomitant administration of Sotret with specific prescription or over-the-counter products can produce severe adverse medical events. Patients must avoid dietary supplements containing vitamin A due to the elevated risk of additive hypervitaminosis A toxicity. Co-administration with tetracycline-class antibiotics (such as doxycycline, minocycline, or tetracycline) is strictly contraindicated because the combination increases the risk of benign intracranial hypertension (pseudotumor cerebri), which can result in permanent visual loss. Micro-dosed progesterone-only oral contraceptives (“minipills”) may be rendered ineffective by isotretinoin; alternative reliable birth control forms must be used. Patients must inform their prescriber of all concurrent treatments.

Adverse reactions

Sotret produces dose-dependent adverse reactions across multiple organ systems. Mucocutaneous symptoms are extremely frequent and include severe cheilitis (dry lips), cutaneous dryness, epistaxis (nosebleeds), and xerophthalmia (dry eyes). Musculoskeletal adverse effects, such as back pain, myalgia, and arthralgia, occur regularly during therapy. Serum laboratory monitoring frequently demonstrates elevated plasma triglycerides, elevated serum cholesterol, and transient elevations in liver enzymes (AST, ALT). Central nervous system symptoms, such as persistent headaches or mood alterations, require immediate medical assessment. Contact lens wearers may develop dry eye intolerance and corneal changes requiring temporary suspension of lens use.

Important Precautions

Boxed Warning: Isotretinoin is an extreme human teratogen. Fetal exposure to Sotret during pregnancy causes severe congenital malformations, severe cranial nerve defects, cardiovascular defects, facial dysmorphism, or fetal loss. Females of childbearing potential must register with the mandatory FDA iPLEDGE program, complete two negative pregnancy tests prior to initiation, utilize two independent forms of effective contraception simultaneously for one month prior to, during, and one month following therapy, and complete monthly pregnancy evaluations. Male patients and non-pregnant females must also comply with iPLEDGE registry rules. Additionally, blood donation is strictly prohibited during therapy and for one month after treatment cessation to avoid exposing pregnant transfusion recipients to isotretinoin.

What to avoid while taking it

Alcohol consumption should be strictly limited or avoided entirely during Sotret treatment. Both isotretinoin and alcohol are processed by hepatic pathways; combined intake significantly increases the risk of elevated liver enzymes and severe hypertriglyceridemia, which can trigger acute pancreatitis. Always ingest Sotret capsules with meals to ensure reliable systemic bioavailability. Patients must refrain from taking dietary supplements containing vitamin A or retinoid derivatives to avoid severe cumulative retinoid toxicity.

Severe Red Flag Symptoms

Immediate emergency medical attention is required if you experience severe systemic reactions during Sotret therapy. Stop taking the drug and seek prompt medical care if you develop signs of increased intracranial pressure, severe abdominal pain, persistent nausea, severe skin rash, jaundice, or acute psychiatric distress.

When to Seek Immediate Medical Help
Red Flag Symptom Potential Underlying Risk
Severe headache, visual disturbances, dizziness, nausea Benign intracranial hypertension (pseudotumor cerebri)
Severe abdominal pain, severe diarrhea, rectal bleeding Acute pancreatitis or inflammatory bowel disease
Depressed mood, suicidal ideation, severe anxiety Severe psychiatric emergence
Yellowing of the eyes or skin, dark urine Hepatic injury or severe elevated liver enzymes
Severe blistering rash, peeling skin, mucosal lesions Severe cutaneous adverse reactions (e.g., Stevens-Johnson syndrome)

Special Populations

The safety and effectiveness of Sotret in pediatric patients under 12 years of age have not been established. Pediatric use requires close evaluation due to potential musculoskeletal risks, including premature epiphyseal closure in growing bones. Clinical studies in elderly populations are limited; prescribing in older adults must account for reduced hepatic, renal, or cardiac function. Patients with preexisting renal impairment, hepatic disease, or hyperlipidemia require conservative dosing schedules and intensive laboratory monitoring throughout treatment.

Storage and Expiration

Store Sotret capsules at controlled room temperature between 68°F and 77°F (20°C to 25°C), with permitted excursions between 59°F and 86°F (15°C to 30°C). Keep capsules in the original container, tightly closed, and protected from light, moisture, and high heat. Do not store this medication in humid bathroom environments. Keep out of reach of children and domestic animals. Dispose of unused or expired capsules safely according to FDA guidelines; never flush capsules down toilets or drains.

Frequently Asked Questions

Why is the iPLEDGE program required for receiving Sotret?

The iPLEDGE program is a mandatory risk evaluation and mitigation strategy (REMS) mandated by the FDA in the United States. Its primary objective is to prevent fetal exposure to isotretinoin due to the extremely high risk of severe birth defects. All prescribers, pharmacies, and patients must register and fulfill strict requirements–including negative pregnancy tests and double-contraception confirmation for females of reproductive potential–before the drug can be dispensed.

What should I do if I accidentally miss a dose?

If you miss a dose of Sotret, skip the missed capsule entirely and take your next dose at the regularly scheduled time. Do not double the dose or take extra medicine to make up for a missed capsule. Maintaining your regular dosing schedule helps prevent unnecessary systemic toxicity while preserving overall treatment consistency.

Can I undergo cosmetic skin procedures like laser treatment or waxing while taking Sotret?

No, patients taking Sotret must avoid cosmetic skin treatments, including wax epilation, laser skin resurfacing, and dermabrasion, during treatment and for at least 6 months after stopping the medication. Isotretinoin alters epithelial tissue repair, dramatically increasing the risk of severe epidermal stripping, scarring, or hyperpigmentation.

Why are frequent blood tests necessary during therapy?

Regular blood monitoring is essential during Sotret therapy to evaluate metabolic safety. Prescribers monitor serum lipid panels (triglycerides and cholesterol), hepatic transaminases, and blood cell counts to detect drug-induced abnormalities early. For female patients of childbearing potential, routine monthly blood or urine pregnancy tests are mandatory prior to obtaining each monthly prescription refill.

Does Sotret impair night vision or driving abilities?

Yes, Sotret can cause a sudden or gradual reduction in night vision, which may occur unpredictably during therapy. Patients should exercise extreme caution when driving or operating heavy machinery after dark. If you experience visual changes, avoid night driving immediately and consult your medical provider for evaluation.

This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.

Additional information
Dosage

20 mg

,

30 mg

Package

30 caps

,

60 caps

,

90 caps

Ενεργός Ουσία